Journal of Global Infectious DiseasesOfficial Publishing of INDUSEM and OPUS 12 Foundation, Inc. Users online:4581  
Print this pageEmail this pageSmall font sizeDefault font sizeIncrease font size     
Home About us Editors Ahead of Print Current Issue Archives Search Instructions Subscribe Advertise Login 
 
This article has been cited by
1Antimonial drugs entrapped into phosphatidylserine liposomes: physicochemical evaluation and antileishmanial activity
Samanta Etel Treiger Borborema,João Alberto Osso Junior,Heitor Franco de Andrade Junior,Nanci do Nascimento
Revista da Sociedade Brasileira de Medicina Tropical.2016;49(2)196
[DOI]
2Applications of Nanomaterials in Leishmaniasis: A Focus on Recent Advances and Challenges
Kiran Saleem,Zainab Khursheed,Christophe Hano,Iram Anjum,Sumaira Anjum
Nanomaterials.2019;9(12)1749
[DOI]
3Drug repurposing and human parasitic protozoan diseases
Katherine T. Andrews,Gillian Fisher,Tina S. Skinner-Adams
International Journal for Parasitology: Drugs and Drug Resistance.2014;4(2)95
[DOI]
4Macrophage targeted amphotericin B nanodelivery systems against visceral leishmaniasis
Pankaj Kumar Singh,Bapi Gorain,Hira Choudhury,Sachin Kumar Singh,Pankaj Whadwa,Pankaj Shilpa,Sanjeev Sahu,Monica Gulati,Prashant Kesharwani
Materials Science and Engineering: B.2020;258(2)114571
[DOI]
5Assessing the Efficacy and Safety of Liposomal Amphotericin B and Miltefosine in Combination for Treatment of Post Kala-Azar Dermal Leishmaniasis
V Ramesh,Keerti Kaumudee Dixit,Neha Sharma,Ruchi Singh,Poonam Salotra
The Journal of Infectious Diseases.2020;221(4)608
[DOI]
6Evaluation of synergy between host and pathogen-directed therapies against intracellular Leishmania donovani
M. Shamim Hasan Zahid,Monica M. Johnson,Robert J. Tokarski,Abhay R. Satoskar,James R. Fuchs,Eric M. Bachelder,Kristy M. Ainslie
International Journal for Parasitology: Drugs and Drug Resistance.2019;10(4)125
[DOI]
7Whole Blood Stimulation Assay as a Treatment Outcome Monitoring Tool for VL Patients in Ethiopia: A Pilot Evaluation
Yetemwork Aleka,Ana Victoria Ibarra-Meneses,Meseret Workineh,Fitsumbrhan Tajebe,Amare Kiflie,Mekibib Kassa Tessema,Roma Melkamu,Azeb Tadesse,Javier Moreno,Johan van Griensven,Eugenia Carrillo,Wim Adriaensen
Journal of Immunology Research.2020;2020(4)1
[DOI]
8Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects
Mahshid Mostafavi,Iraj Sharifi,Saeedeh Farajzadeh,Payam Khazaeli,Hamid Sharifi,Elnaz Pourseyedi,Sina Kakooei,Mehdi Bamorovat,Alireza Keyhani,Maryam Hakimi Parizi,Ahmad Khosravi,Ali Khamesipour
Biomedicine & Pharmacotherapy.2019;116(4)108942
[DOI]
9Niosomal formulation of amphotericin B alone and in combination with glucantime: In vitro and in vivo leishmanicidal effects
Sarah Hendrickx,Louis Maes,Simon L. Croft,Guy Caljon
Biomedicine & Pharmacotherapy.2018;116(4)193
[DOI]
10Development of effective AmB/AmB–aCD complex double loaded liposomes using a factorial design for systemic fungal infection treatment
N. Basaran Mutlu-Agardan,Sukran Yilmaz,Fatma Kaynak Onurdag,Nevin Celebi
Journal of Liposome Research.2020;116(4)1
[DOI]
11Development of effective AmB/AmB–aCD complex double loaded liposomes using a factorial design for systemic fungal infection treatment
Praveena Velpurisiva,Janel L. Kydd,Rahul Jadia,Stephanie A. Morris,Prakash Rai
Journal of Liposome Research.2019;5(4)3
[DOI]
12Emerging therapeutic targets for treatment of leishmaniasis
Shyam Sundar,Bhawana Singh
Expert Opinion on Therapeutic Targets.2018;22(6)467
[DOI]
13Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art
REBECCA L. CHARLTON,BARTIRA ROSSI-BERGMANN,PAUL W. DENNY,PATRICK G. STEEL
Parasitology.2018;145(2)219
[DOI]
14Formulation, characterization and in vitro anti-leishmanial evaluation of amphotericin B loaded solid lipid nanoparticles coated with vitamin B12-stearic acid conjugate
Aakriti Singh,Ganesh Yadagiri,Shabi Parvez,Om Prakash Singh,Anurag Verma,Shyam Sundar,Shyam Lal Mudavath
Materials Science and Engineering: C.2020;117(2)111279
[DOI]
15Amphotericin B Membrane Action: Role for Two Types of Ion Channels in Eliciting Cell Survival and Lethal Effects
B. Eleazar Cohen
The Journal of Membrane Biology.2010;238(1-3)1
[DOI]
16Stability and toxicity of heteroleptic organometallic Bi(v) complexes towards Leishmania major
Yih Ching Ong,Victoria L. Blair,Lukasz Kedzierski,Philip C. Andrews
Dalton Trans..2014;43(34)12904
[DOI]
17Plants as Antileishmanial Agents: Current Scenario
Nazif Ullah,Akhtar Nadhman,Sumaira Siddiq,Shaila Mehwish,Arshad Islam,Laila Jafri,Muhammad Hamayun
Phytotherapy Research.2016;30(12)1905
[DOI]
18Plants as Antileishmanial Agents: Current Scenario
Philippe M. Loiseau,Gillian Barratt
Phytotherapy Research.2013;30(12)321
[DOI]
19Leishmanicidal effects of amphotericin B in combination with selenium loaded on niosome against Leishmania tropica
Mahshid Mostafavi,Saeedeh Farajzadeh,Iraj Sharifi,Payam Khazaeli,Hamid Sharifi
Journal of Parasitic Diseases.2019;43(2)176
[DOI]
20Liposomal formulations in the pharmacological treatment of leishmaniasis: a review
Vanessa Ortega,Selma Giorgio,Eneida de Paula
Journal of Liposome Research.2017;27(3)234
[DOI]
21Oral azithromycin versus its combination with miltefosine for the treatment of experimental Old World cutaneous leishmaniasis
Eglal I. Amer,Maha M. Eissa,Shereen F. Mossallam
Journal of Parasitic Diseases.2016;40(2)475
[DOI]
22Antimicrobial Peptides-based Nanostructured Delivery Systems: An Approach for Leishmaniasis Treatment
Adrian Rodríguez-Carlos,Fidel Martinez-Gutierrez,Flor Torres-Juarez,Bruno Rivas-Santiago
Current Pharmaceutical Design.2019;25(14)1593
[DOI]
23Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform
Ruwandi Kariyawasam,Priyanka Challa,Rachel Lau,Andrea K. Boggild
BMC Infectious Diseases.2019;19(1)1593
[DOI]
24Susceptibility testing of Leishmania spp. against amphotericin B and fluconazole using the Sensititre™ YeastOne™ YO9 platform
Sujit K. Bhattacharya,Ajanta Ghosal,Sudeshna Ganguly,Sandipan Ganguly,Sabahat Azim,Shanta Dutta
BMC Infectious Diseases.2018;19(1)1593
[DOI]
25Identification of Phenylphthalazinones as a New Class of Leishmania infantum Inhibitors
Maarten Sijm,Erik Heuvel,An Matheeussen,Guy Caljon,Louis Maes,Geert-Jan Sterk,Iwan J. P. Esch,Rob Leurs
ChemMedChem.2020;15(2)219
[DOI]
26Concerted motion of structure and active site charge is required for tyrosine aminotransferase activity in Leishmania parasite
Santanu Sasidharan,Prakash Saudagar
Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy.2020;232(2)118133
[DOI]
27Review on natural products as an alternative to contemporary anti-leishmanial therapeutics
Shweta Raj,Santanu Sasidharan,S. N. Balaji,Vikash Kumar Dubey,Prakash Saudagar
Journal of Proteins and Proteomics.2020;11(2)135
[DOI]
28Lipid based delivery and immuno-stimulatory systems: Master tools to combat leishmaniasis
Abdus Sabur,Mohammad Asad,Nahid Ali
Cellular Immunology.2016;309(2)55
[DOI]
29Poly(methacrylic acid) complexation of amphotericin B to treat neglected diseases
Karolina Alicja Les,Abeer H. A. Mohamed-Ahmed,Sibu Balan,Ji-won Choi,Denis Martin,Vanessa Yardley,Keith Powell,Antony Godwin,Steve Brocchini
Polym. Chem..2014;5(3)1037
[DOI]
30Gelatin nanofiber assisted zero order release of Amphotericin-B: A study with realistic drug loading for oral formulation
Mrunalini Gaydhane,Pankaj Choubey,Chandra S. Sharma,Saptarshi Majumdar
Materials Today Communications.2020;24(3)100953
[DOI]
31A ReplicativeIn VitroAssay for Drug Discovery against Leishmania donovani
Diana Tegazzini,Rosario Díaz,Fernando Aguilar,Imanol Peña,Jesús L. Presa,Vanessa Yardley,Julio J. Martin,Jose M. Coteron,Simon L. Croft,Juan Cantizani
Antimicrobial Agents and Chemotherapy.2016;60(6)3524
[DOI]
32Stability and toxicity of tris-tolyl bismuth(v) dicarboxylates and their biological activity towards Leishmania major
Yih Ching Ong,Victoria L. Blair,Lukasz Kedzierski,Kellie L. Tuck,Philip C. Andrews
Dalton Transactions.2015;44(41)18215
[DOI]
33Biochemical and structural characterization of tyrosine aminotransferase suggests broad substrate specificity and a two-state folding mechanism in Leishmania donovani
Santanu Sasidharan,Prakash Saudagar
FEBS Open Bio.2019;9(10)1769
[DOI]
34Rare splenic complications and specific serology: decisive diagnostic tools in two cases of visceral leishmaniasis
Andrea Celestini,Federica Paglia,Orlando Dell’ Unto,Riccardo Guarisco,Claudio Puoti
Italian Journal of Medicine.2011;5(4)274
[DOI]
35Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B
Md. Shadab,Baijayanti Jha,Mohammad Asad,Makaraju Deepthi,Mohd. Kamran,Nahid Ali,Gautam Chaudhuri
PLOS ONE.2017;12(2)e0171306
[DOI]
36Apoptosis-like cell death in Leishmania donovani treated with KalsomeTM10, a new liposomal amphotericin B
María Jesús Corral-Caridad,José María Alunda
PLOS ONE.2013;12(2)17
[DOI]
37Modes of action of Leishmanicidal antimicrobial peptides
Alexandra K Marr,Bradford S McGwire,W Robert McMaster
Future Microbiology.2012;7(9)1047
[DOI]
38Natural products and phytotherapy: an innovative perspective in leishmaniasis treatment
Luiz Filipe Gonçalves de Oliveira,Bernardo Acácio Santini Pereira,Benjamin Gilbert,Arthur Luiz Corrêa,Leandro Rocha,Carlos Roberto Alves
Phytochemistry Reviews.2017;16(2)219
[DOI]
39Urbanização da leishmaniose visceral: aspectos clínicos e epidemiológicos em Aracaju, Sergipe, Brasil
Marco Aurélio Oliveira Góes,Verònica de Lourdes Sierpe Jeraldo,Alex Santana Oliveira
Revista Brasileira de Medicina de Família e Comunidade.2013;9(31)119
[DOI]
40Epidemiological profile of patients co-infected with visceral leishmaniasis and HIV/AIDS in Northeast, Brazil
Graça Maria de Castro Viana,Marcos Antonio Custódio Neto da Silva,João Victor de Sousa Garcia,Helaine Dias Guimarães,Gelson Farias Arcos Júnior,Augusto Viana Arouche Santos,Pedro Viana da Paixão,Maria do Desterro Soares Brandão Nascimento,Carolina de Souza Galvão
Revista da Sociedade Brasileira de Medicina Tropical.2017;50(5)613
[DOI]
41Clinical aspects of visceral leishmaniasis caused by L. infantum in adults. Ten years of experience of the largest outbreak in Europe: what have we learned?
Luis Horrillo,Alicia Castro,Belén Matía,Laura Molina,Jesús García-Martínez,Jerónimo Jaqueti,Isabel García-Arata,Eugenia Carrillo,Javier Moreno,José Manuel Ruiz-Giardin,Juan San Martín
Parasites & Vectors.2019;12(1)613
[DOI]
42Clinical aspects of visceral leishmaniasis caused by L. infantum in adults. Ten years of experience of the largest outbreak in Europe: what have we learned?
Abeer H. A. Mohamed-Ahmed,Claire Ginn,Simon L. Croft,Stephen Brocchini
Parasites & Vectors.2013;12(1)429
[DOI]
43Leishmaniasis and various immunotherapeutic approaches
Y. TASLIMI,F. ZAHEDIFARD,S. RAFATI
Parasitology.2018;145(4)497
[DOI]
44Leishmaniasis and various immunotherapeutic approaches
Nasib Singh,Pooja Devi Gautam,Puja Kumari Chauhan,Tanvir Kaur,Karan Singh,Joginder Singh,Sumit Singh Dagar
Parasitology.2019;28(4)27
[DOI]
45HIV/AIDS-related visceral leishmaniasis: a clinical and epidemiological description of visceral leishmaniasis in northern Brazil
Leonardo Cordenonzi Pedroso de Albuquerque,Iatan Rezende Mendonça,Polyana Nascimento Cardoso,Leonardo Rodrigo Baldaçara,Myrlena Regina Machado Mescouto Borges,Joelma da Costa Borges,Maria Cristina da Silva Pranchevicius
Revista da Sociedade Brasileira de Medicina Tropical.2014;47(1)38
[DOI]
46The pore-forming action of polyenes: From model membranes to living organisms
Luka Kristanc,Bojan Božic,Špela Zemljic Jokhadar,Marija Sollner Dolenc,Gregor Gomišcek
Biochimica et Biophysica Acta (BBA) - Biomembranes.2019;1861(2)418
[DOI]
47Therapeutic Interventions for Countering Leishmaniasis and Chagas’s Disease: From Traditional Sources to Nanotechnological Systems
Eliana B. Souto,João Dias-Ferreira,Sara A. Craveiro,Patrícia Severino,Elena Sanchez-Lopez,Maria L. Garcia,Amélia M. Silva,Selma B. Souto,Sheefali Mahant
Pathogens.2019;8(3)119
[DOI]
48Improved Oral Bioavailability and Gastrointestinal Stability of Amphotericin B through Fatty Acid Conjugation Approach
Kaushik Thanki,Tushar Date,Sanyog Jain
Molecular Pharmaceutics.2019;16(11)4519
[DOI]
49Lathosterol Oxidase (Sterol C-5 Desaturase) Deletion Confers Resistance to Amphotericin B and Sensitivity to Acidic Stress in Leishmania major
Yu Ning,Cheryl Frankfater,Fong-Fu Hsu,Rodrigo P. Soares,Camila A. Cardoso,Paula M. Nogueira,Noelia Marina Lander,Roberto Docampo,Kai Zhang,Margaret Phillips
mSphere.2020;5(4)4519
[DOI]
50Unravelling the rate of action of hits in the Leishmania donovani box using standard drugs amphotericin B and miltefosine
Diana Tegazzini,Juan Cantizani,Imanol Peña,Julio Martín,Jose M. Coterón,Michael P. Pollastri
PLOS Neglected Tropical Diseases.2017;11(5)e0005629
[DOI]
51Multi-target drugs active against leishmaniasis: A paradigm of drug repurposing
Susana Santos Braga
European Journal of Medicinal Chemistry.2019;183(5)111660
[DOI]
52In-vitroantileishmanial potential of peptide drug hirudin
Hanif Khan,Akhtar Nadhman,Syed Sikander Azam,Mariam Anees,Imran Khan,Ikram Ullah,Muhammad Farhan Sohail,Gul Shahnaz,Masoom Yasinzai
Chemical Biology & Drug Design.2017;89(1)67
[DOI]
53Antileishmanial assessment of isoxazole derivatives against L. donovani
Sushobhan Mukhopadhyay,Dinesh S. Barak,R. Karthik,Sarvesh K. Verma,Rabi S. Bhatta,Neena Goyal,Sanjay Batra
RSC Medicinal Chemistry.2020;89(1)67
[DOI]
54Short-course Regimens of Liposomal Amphotericin B for the Treatment of Mediterranean Visceral Leishmaniasis in Children
Panagiotis Krepis,Ioanna Argyri,Adamantia Krepi,Areti Syrmou,Nikos Spyridis,Maria Tsolia
The Pediatric Infectious Disease Journal.2017;36(9)849
[DOI]
55Hepatotoxicity of Antimycotics Used for Invasive Fungal Infections: In Vitro Results
Sandra Doß,Heike Potschka,Fanny Doß,Steffen Mitzner,Martin Sauer
BioMed Research International.2017;2017(9)1
[DOI]
56Treatment of Disseminated Leishmaniasis With Liposomal Amphotericin B
Paulo R. L. Machado,Maria Elisa A. Rosa,Luís H. Guimarães,Fernanda V. O. Prates,Adriano Queiroz,Albert Schriefer,Edgar M. Carvalho
Clinical Infectious Diseases.2015;61(6)945
[DOI]
57Potential therapeutic targets and the role of technology in developing novel antileishmanial drugs
Rajalakshmi Rajasekaran,Yi-Ping Phoebe Chen
Drug Discovery Today.2015;20(8)958
[DOI]
58Ruthenium-Clotrimazole complex has significant efficacy in the murine model of cutaneous leishmaniasis
Eva Iniguez,Armando Varela-Ramirez,Alberto Martínez,Caresse L. Torres,Roberto A. Sánchez-Delgado,Rosa A. Maldonado
Acta Tropica.2016;164(8)402
[DOI]
59Ruthenium-Clotrimazole complex has significant efficacy in the murine model of cutaneous leishmaniasis
Goutam Mandal,Vaidya Govindarajan,Mansi Sharma,Hiranmoy Bhattacharjee,Rita Mukhopadhyay
Acta Tropica.2017;164(8)649
[DOI]
60Evaluating the immunomodulatory responses of Ld ODC-derived MHC Class-II restricted peptides against VL
RajKishor Pandey,Manas Ranjan Dikhit,Avinash Kumar,Budheswar Dehury,Krishna Pandey,Roshan Kamal Topno,Pradeep Das,Sanjiva Bimal
Parasite Immunology.2020;42(4)649
[DOI]
61A novel mechanism for an old drug: Amphotericin B in the treatment of visceral leishmaniasis
Amitabha Chattopadhyay,Md. Jafurulla
Biochemical and Biophysical Research Communications.2011;416(1-2)7
[DOI]
62Vector Saliva in Vaccines for Visceral Leishmaniasis: A Brief Encounter of High Consequence?
Shaden Kamhawi,Hamide Aslan,Jesus G. Valenzuela
Frontiers in Public Health.2014;2(1-2)7
[DOI]
63Noncovalent Complexation of Amphotericin-B with Poly(a-glutamic acid)
Abeer H. A. Mohamed-Ahmed,Karolina A. Les,Karin Seifert,Simon L. Croft,Stephen Brocchini
Molecular Pharmaceutics.2013;10(3)940
[DOI]
64Treating an old disease with new tricks: strategies based on host–guest chemistry for leishmaniasis therapy
Susana Santos Braga
Journal of Inclusion Phenomena and Macrocyclic Chemistry.2019;93(3-4)145
[DOI]
65Análisis de la utilización de anfotericina B liposomal
María González Martínez,Carolina Mariño Martínez,Gema Baldominos Utrilla,María Nélida Fernández Martínez
Revista Iberoamericana de Micología.2014;31(2)109
[DOI]
66LeishInDB: A web-accessible resource for small molecule inhibitors against Leishmania sp
Saravanan Vijayakumar,Vishnu Kant,Pradeep Das
Acta Tropica.2019;190(2)375
[DOI]
67The Development of Oral Amphotericin B to Treat Systemic Fungal and Parasitic Infections: Has the Myth Been Finally Realized?
Grace Cuddihy,Ellen Wasan,Yunyun Di,Kishor Wasan
Pharmaceutics.2019;11(3)99
[DOI]
68A pilot study comparing low-dose liposomal amphotericin B with N-methyl glucamine for the treatment of American cutaneous leishmaniasis
J.O.C. Motta,R.N.R. Sampaio
Journal of the European Academy of Dermatology and Venereology.2012;26(3)331
[DOI]
69A pilot study comparing low-dose liposomal amphotericin B with N-methyl glucamine for the treatment of American cutaneous leishmaniasis
Alan J Magill
Journal of the European Academy of Dermatology and Venereology.2013;26(3)739
[DOI]
70Mapping N- and C-terminals of Leishmania donovani tyrosine aminotransferase by gene truncation strategy: a functional study using in vitro and in silico approaches
Santanu Sasidharan,Prakash Saudagar
Scientific Reports.2020;10(1)739
[DOI]
71Nigella sativa oil entrapped polycaprolactone nanoparticles for leishmaniasis treatment
Emrah Sefik Abamor,Ozlem Ayse Tosyali,Melahat Bagirova,Adil Allahverdiyev
IET Nanobiotechnology.2018;12(8)1018
[DOI]
72Drug repurposing: a promising tool to accelerate the drug discovery process
Vineela Parvathaneni,Nishant S. Kulkarni,Aaron Muth,Vivek Gupta
Drug Discovery Today.2019;24(10)2076
[DOI]
73Recent progress in drug targets and inhibitors towards combating leishmaniasis
Saravanan Vijayakumar,Pradeep Das
Acta Tropica.2018;181(10)95
[DOI]
74Different Mutations in a P-type ATPase Transporter in Leishmania Parasites are Associated with Cross-resistance to Two Leading Drugs by Distinct Mechanisms
Christopher Fernandez-Prada,Isabel M. Vincent,Marie-Christine Brotherton,Mathew Roberts,Gaétan Roy,Luis Rivas,Philippe Leprohon,Terry K. Smith,Marc Ouellette,Louis Maes
PLOS Neglected Tropical Diseases.2016;10(12)e0005171
[DOI]
  Addresses 
  My Preferences 


JGID
What's new
Forthcoming Symposia
Submit articles
Email alerts
Join us
Most popular articles
Recommend this journal
Sitemap | What's New | Feedback | Copyright and Disclaimer | Contact Us
© 2008 Journal of Global Infectious Diseases | Published by Wolters Kluwer - Medknow
Online since 10th December, 2008